Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

421 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry.
Gragnano F, Moscarella E, Calabrò P, Cesaro A, Pafundi PC, Ielasi A, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pelliccia F, Gaudio C, Sasso FC, Pengo V, Gresele P, Marcucci R; START-ANTIPLATELET Collaborators. Gragnano F, et al. Among authors: palareti g. Intern Emerg Med. 2021 Mar;16(2):379-387. doi: 10.1007/s11739-020-02404-1. Epub 2020 Jun 15. Intern Emerg Med. 2021. PMID: 32557093
D-dimer testing to determine the duration of anticoagulation therapy.
Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A; PROLONG Investigators. Palareti G, et al. N Engl J Med. 2006 Oct 26;355(17):1780-9. doi: 10.1056/NEJMoa054444. N Engl J Med. 2006. PMID: 17065639 Free article. Clinical Trial.
Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
Pengo V, Palareti G, Cucchini U, Molinatti M, Del Bono R, Baudo F, Ghirarduzzi A, Pegoraro C, Iliceto S; participating centers of Italian Federation of Anticoagulation Clinics (FCSA). Pengo V, et al. Among authors: palareti g. Clin Appl Thromb Hemost. 2007 Jul;13(3):241-8. doi: 10.1177/1076029607302544. Clin Appl Thromb Hemost. 2007. PMID: 17636186 Free article. Clinical Trial.
Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.
Poli D, Antonucci E, Testa S, Tosetto A, Ageno W, Palareti G; Italian Federation of Anticoagulation Clinics. Poli D, et al. Among authors: palareti g. Circulation. 2011 Aug 16;124(7):824-9. doi: 10.1161/CIRCULATIONAHA.110.007864. Epub 2011 Aug 1. Circulation. 2011. PMID: 21810658
Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
Poli D, Antonucci E, Testa S, Ageno W, Palareti G; FCSA (Italian Federation of Anticoagulation Clinics). Poli D, et al. Among authors: palareti g. Thromb Res. 2013 Jan;131(1):12-6. doi: 10.1016/j.thromres.2012.10.009. Epub 2012 Nov 8. Thromb Res. 2013. PMID: 23141847
Clinical management of rivaroxaban-treated patients.
Palareti G, Ageno W, Ferrari A, Filippi A, Imberti D, Pengo V, Rubboli A, Toni D. Palareti G, et al. Expert Opin Pharmacother. 2013 Apr;14(5):655-67. doi: 10.1517/14656566.2013.773310. Epub 2013 Feb 17. Expert Opin Pharmacother. 2013. PMID: 23414291 Review.
421 results